BioSpace News Archive

Prevnar 20 is indicated for the prevention of invasive pneumococcal disease and otitis media in children.

In the Phase III SURMOUNT-2 study, Mounjaro reduced body weight by 29.8 lbs. on average in adult type 2 diabetes patients who were overweight or obese.

As Humira global revenues fall 25%, AbbVie looks to Rinvoq and Skyrizi to fill in the gap. The company also announced it is cutting cystic fibrosis and Crohn’s disease candidates.

Who can detect clinically significant prostate cancer better, a radiologist or Artificial Intelligence model? How does prostate cancer have an impact on the sexual health of female partners of survivors?

Avinger, Inc. today announced the presentation of clinical data from the INSIGHT study during the Charing Cross (CX) International Symposium in London, England.

GeneDx today announced that its board of directors has approved a 1-for-33 reverse stock split of the Company’s Class A common stock.

Which YouTube videos can you trust talking about penile augmentation? Has the average size of a penis increased? Are there meaningful differences in drug choice for men with coronary artery disease and erectile dysfunction?

OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced positive headline results of a phase 2a trial in the treatment of hypertrophic scars which met the primary observer-based endpoint at week 24 as evaluated by the Patient and Observer Scar Assessment Scale (POSAS).

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, announced that Shaun Bagai, CEO of RenovoRx, will present at the Aegis Capital Virtual Conference on May 3rd at 3:30 p.m. ET.

LAMF Global Ventures Corp I announced today that they have entered into a non-binding letter of intent (the “LOI”) for a proposed business combination.